EDSA News and Press, Edesa Biotech Inc. From 02/24/26

A look at the top 10 most actives in the United States Direxion Daily Semiconductor Bear 3X Shares (SOXS) fell 5.2% to $1.6499 on volume of 551,178,425 shares Blue Hat Interactive Entertainment Technology (BHAT) rose 9.3% to $0.0719 on volume of 251,273,331 shares Reliance Global Group Inc....

2026-02-24 12:44:00 ET Biotech Stock Edesa Biotech (Nasdaq:EDSA) Gains on News of Additional Positive Results from Phase 3 Paridiprubart Study Published on Feb 24, 2026 ( Investorideas.com Newswire) a go-to platform ...

Results in a population of 278 patients affirm statistically significant mortality reductions Benefits observed across severity groups and in subjects with serious comorbidities Company files provisional patent applications for sepsis, acute kidney injury and pneumonia Strategic collabor...

2026-02-13 16:29:16 ET More on Edesa Biotech Edesa Biotech, Inc. (EDSA) Presents at LSX Investival Showcase Europe 2025 - Slideshow Seeking Alpha’s Quant Rating on Edesa Biotech Historical earnings data for Edesa Biotech Financial information for Edesa...

TORONTO, Feb. 13, 2026 (GLOBE NEWSWIRE) -- Edesa Biotech, Inc. (Nasdaq:EDSA), a clinical-stage biopharmaceutical company focused on developing host-directed therapeutics for immuno-inflammatory diseases, today reported financial results for the three months ended December 31, 2025 and provided an...

Air Canada Inc. (ACDVF) is expected to report $0.2 for Q4 2025 Edesa Biotech Inc. (EDSA) is expected to report $-0.28 for Q1 2026 Advance Auto Parts Inc. (AAP) is expected to report $0.41 for Q4 2025 Neuphoria Therapeutics Inc. (NEUP) is expected to report $-0.56 for Q2 2026 Kirin...

2025-12-14 23:38:16 ET More on Edesa Biotech Edesa Biotech, Inc. (EDSA) Presents at LSX Investival Showcase Europe 2025 - Slideshow Seeking Alpha’s Quant Rating on Edesa Biotech Historical earnings data for Edesa Biotech Financial information for Edesa...

TORONTO, Dec. 12, 2025 (GLOBE NEWSWIRE) -- Edesa Biotech, Inc. (Nasdaq:EDSA), a clinical-stage biopharmaceutical company focused on developing host-directed therapeutics for immuno-inflammatory diseases, today reported financial results for the fiscal year ended September 30, 2025 and provided an...

Edesa Biotech Inc. (EDSA) is expected to report $-0.27 for Q4 2025 Johnson Outdoors Inc. (JOUT) is expected to report $-0.68 for Q4 2025 Trinity Biotech plc (TRIB) is expected to report $-1.48 for Q3 2025

TORONTO, Oct. 31, 2025 (GLOBE NEWSWIRE) -- Edesa Biotech, Inc. (Nasdaq:EDSA), a clinical-stage biopharmaceutical company focused on developing host-directed therapeutics for immuno-inflammatory diseases, announced today that Edesa management and business development staff plan to participate in t...